
CAS 1103522-45-7
:Aprocitentan
- Act-132577
Despropyl Macitentan (N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]sulfamide)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C16H14Br2N6O4SCouleur et forme :Off-White SolidMasse moléculaire :543.9164ACT-132577
CAS :Formule :C16H14Br2N6O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :546.1932Ref: IN-DA008TD9
1gÀ demander1mg157,00€5mg161,00€10mg191,00€25mg240,00€50mg602,00€100mgÀ demander250mgÀ demanderN-Despropyl Macitentan (Aprocitentan)
CAS :Formule :C16H14Br2N6O4SCouleur et forme :White To Off-White SolidMasse moléculaire :546.20Aprocitentan
CAS :Aprocitentan (ACT-132577) is ETA and ETB antagonist .Formule :C16H14Br2N6O4SDegré de pureté :99.17%Couleur et forme :SolidMasse moléculaire :546.19Ref: TM-T7817
1mg58,00€5mg116,00€10mg170,00€25mg311,00€50mg439,00€100mg655,00€200mg887,00€1mL*10mM (DMSO)142,00€N-Despropyl-macitentan
CAS :Produit contrôléApplications N-Despropyl-macitentan, is an active metabolite which is part of a family of endothelin receptor antagonist that allows for treatment of pulmonary arterial hypertension (PAH)
References Atsmon, J., et al.: Clin. Pharmacokinet., 525, 685 (2013); Sidharta, P.N., et al.: Clin. Drug Invest. (2014)Formule :C16H14Br2N6O4SCouleur et forme :NeatMasse moléculaire :546.19Aprocitentan
CAS :Apcitentan is a vasoactive drug that belongs to the group of endothelin receptor antagonists. It is used in the treatment of erectile dysfunction and pulmonary hypertension. Apcitentan inhibits the angiotensin system, which includes angiotensin-converting enzyme (ACE), angiotensin II type 1 receptor (AT1R) and angiotensin II type 2 receptor (AT2R). This inhibition increases the levels of endothelin and dopamine β-hydroxylase, thereby decreasing blood pressure. Apcitentan has been shown to increase glomerular filtration rate and reduce proteinuria in patients with chronic kidney disease. In vivo studies have shown that apcitentan is rapidly absorbed from the gastrointestinal tract, reaching peak concentrations within one hour. The pharmacodynamics of apcitentan are characterized by an inhibitory effect on pde5. Pharmacokinetic studies have found that apcitentan is metabolized by CYP
Formule :C16H14Br2N6O4SDegré de pureté :Min. 95%Masse moléculaire :546.19 g/mol









